Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024283645> ?p ?o ?g. }
- W2024283645 endingPage "2585" @default.
- W2024283645 startingPage "2578" @default.
- W2024283645 abstract "Regulatory T cells (Tregs) in peripheral blood and tumor infiltrating lymphocytes (TILs) play crucial roles in suppressing anti-tumor immune responses in cancer patients, and correlate with clinical outcomes. We identified an important subpopulation, CD13+CD4+CD25hiTreg cells, among CD4+CD25hiTreg cells in the peripheral blood of non-small cell lung cancer (NSCLC) patients. Peripheral blood mononuclear cells (PBMCs) were isolated from patients with NSCLC (n = 72) or from healthy donors (n = 30). Flow cytometric analyses were performed to study the expression of cell-surface or intracellular markers on the CD4+CD25hiTreg cells. The immune suppressive function of CD13+CD4+CD25hiTreg cells was evaluated by co-culturing with CD4+CD25-T cells that were activated by PHA. Our data showed that, compared with CD4+CD25(Low/-)T cells, CD13 expression was enriched on CD4+CD25hiTreg cells. The CD13+CD4+CD25hiTreg cells also expressed higher levels of Foxp3, CTLA-4, membrane-bound transforming growth factor beta1 (mTGFbeta1) and B7-H1, and are more suppressive to CD25 expression and proliferation of CD4+CD25-T cells. Additionally, we showed that the expression of Foxp3, CTLA-4, B7-H1, mTGFbeta1 and the secretion of TGFbeta1 and IL-10 on CD13+CD4+CD25hiTreg cells was significantly suppressed by anti-CD13 mAb (WM15), and the ability of these cells to suppress CD25 expression and proliferation of CD4+CD25-T cells was inhibited by WM15 as well. Interestingly, the percentage of CD13+CD4+CD25hiTreg cells among the CD4+CD25hiTreg population increased significantly and correlated with pathological stage in NSCLC: healthy donor (9.84% +/- 2.23%) <stage I (21.64% +/- 2.78%) <stage II (31.86% +/- 3.01%) <stage III (45.64% +/- 6.12%) <stage IV (58.78% +/- 12.89%). Moreover, the percentage of CD13+CD4+CD25hiTreg cells decreased dramatically after surgical removal of tumors. CD13 is a new surface molecule for identifying a CD4+CD25hiTreg cell subpopulation with higher suppressive ability. The percentage of CD13+CD4+CD25hiTreg cells among the CD4+CD25hiTreg cell population correlated with the pathological stage in NSCLC and tumor burden. CD13 represents a potential target to suppress Treg cells in anti-tumor therapy." @default.
- W2024283645 created "2016-06-24" @default.
- W2024283645 creator A5017998243 @default.
- W2024283645 creator A5020615028 @default.
- W2024283645 creator A5024897978 @default.
- W2024283645 creator A5049678335 @default.
- W2024283645 creator A5055055532 @default.
- W2024283645 creator A5061281909 @default.
- W2024283645 creator A5069019411 @default.
- W2024283645 creator A5069178407 @default.
- W2024283645 creator A5071773009 @default.
- W2024283645 creator A5078204635 @default.
- W2024283645 creator A5087171601 @default.
- W2024283645 creator A5087738265 @default.
- W2024283645 date "2009-08-15" @default.
- W2024283645 modified "2023-10-09" @default.
- W2024283645 title "CD13<sup>+</sup>CD4<sup>+</sup>CD25<sup>hi</sup>regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients" @default.
- W2024283645 cites W114265597 @default.
- W2024283645 cites W1486722793 @default.
- W2024283645 cites W1522859339 @default.
- W2024283645 cites W1560277370 @default.
- W2024283645 cites W1567420244 @default.
- W2024283645 cites W1612801297 @default.
- W2024283645 cites W1972140669 @default.
- W2024283645 cites W1973817001 @default.
- W2024283645 cites W1980036500 @default.
- W2024283645 cites W2002726823 @default.
- W2024283645 cites W2005530597 @default.
- W2024283645 cites W2006193946 @default.
- W2024283645 cites W2039638418 @default.
- W2024283645 cites W2061997939 @default.
- W2024283645 cites W2062142808 @default.
- W2024283645 cites W2067490046 @default.
- W2024283645 cites W2073310925 @default.
- W2024283645 cites W2095091733 @default.
- W2024283645 cites W2097074641 @default.
- W2024283645 cites W2097811455 @default.
- W2024283645 cites W2102537478 @default.
- W2024283645 cites W2107031620 @default.
- W2024283645 cites W2107336310 @default.
- W2024283645 cites W2108165275 @default.
- W2024283645 cites W2113030185 @default.
- W2024283645 cites W2123149440 @default.
- W2024283645 cites W2130486201 @default.
- W2024283645 cites W2135398071 @default.
- W2024283645 cites W2136757504 @default.
- W2024283645 cites W2138163780 @default.
- W2024283645 cites W2139191751 @default.
- W2024283645 cites W2140633375 @default.
- W2024283645 cites W2140900100 @default.
- W2024283645 cites W2145997607 @default.
- W2024283645 cites W2147350757 @default.
- W2024283645 cites W2150678612 @default.
- W2024283645 cites W2153873453 @default.
- W2024283645 cites W2157620815 @default.
- W2024283645 cites W2157946967 @default.
- W2024283645 cites W2160117150 @default.
- W2024283645 cites W2167523219 @default.
- W2024283645 cites W2313403466 @default.
- W2024283645 cites W2335128695 @default.
- W2024283645 cites W93318950 @default.
- W2024283645 doi "https://doi.org/10.4161/cc.8.16.9302" @default.
- W2024283645 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19597336" @default.
- W2024283645 hasPublicationYear "2009" @default.
- W2024283645 type Work @default.
- W2024283645 sameAs 2024283645 @default.
- W2024283645 citedByCount "28" @default.
- W2024283645 countsByYear W20242836452013 @default.
- W2024283645 countsByYear W20242836452014 @default.
- W2024283645 countsByYear W20242836452015 @default.
- W2024283645 countsByYear W20242836452016 @default.
- W2024283645 countsByYear W20242836452019 @default.
- W2024283645 countsByYear W20242836452020 @default.
- W2024283645 countsByYear W20242836452021 @default.
- W2024283645 countsByYear W20242836452022 @default.
- W2024283645 crossrefType "journal-article" @default.
- W2024283645 hasAuthorship W2024283645A5017998243 @default.
- W2024283645 hasAuthorship W2024283645A5020615028 @default.
- W2024283645 hasAuthorship W2024283645A5024897978 @default.
- W2024283645 hasAuthorship W2024283645A5049678335 @default.
- W2024283645 hasAuthorship W2024283645A5055055532 @default.
- W2024283645 hasAuthorship W2024283645A5061281909 @default.
- W2024283645 hasAuthorship W2024283645A5069019411 @default.
- W2024283645 hasAuthorship W2024283645A5069178407 @default.
- W2024283645 hasAuthorship W2024283645A5071773009 @default.
- W2024283645 hasAuthorship W2024283645A5078204635 @default.
- W2024283645 hasAuthorship W2024283645A5087171601 @default.
- W2024283645 hasAuthorship W2024283645A5087738265 @default.
- W2024283645 hasBestOaLocation W20242836451 @default.
- W2024283645 hasConcept C126322002 @default.
- W2024283645 hasConcept C129374314 @default.
- W2024283645 hasConcept C137061746 @default.
- W2024283645 hasConcept C153911025 @default.
- W2024283645 hasConcept C202751555 @default.
- W2024283645 hasConcept C203014093 @default.
- W2024283645 hasConcept C2776090121 @default.
- W2024283645 hasConcept C2778296632 @default.
- W2024283645 hasConcept C2779727006 @default.